2015 to 2022 Saw Rise in Ketamine Use
By Lori Solomon HealthDay Reporter
TUESDAY, Jan. 14, 2025 -- There have been shifts in both the patterns and correlates of ketamine use from 2015 to 2022, according to a study published online Jan. 7 in the Journal of Affective Disorders.
Kevin H. Yang, M.D., from the University of California, San Diego, and colleagues used data from the 2015 to 2022 National Survey on Drug Use and Health to examine trends in past-year ketamine use by depression status.
The researchers found that overall ketamine use prevalence increased from 2015 to 2019 (from 0.11 to 0.20 percent; an 81.8 percent increase) and from 2021 to 2022 (from 0.20 to 0.28 percent; a 40.0 percent increase). Use increased from 2015 to 2019 among adults with and without depression (by 139.3 and 66.7 percent, respectively). From 2021 to 2022, an increase occurred only among those without depression (by 38.9 percent). Depression was associated with increased odds of ketamine use in the 2015 to 2019 period (adjusted odds ratio, 1.80) but not in later years. From 2021 to 2022, adults aged 26 to 34 years and those with a college degree had higher odds for use. Higher odds of use were also consistently seen with use of various other drugs, including ecstasy/MDMA and gamma-hydroxybutyrate.
"Monitoring of use patterns is crucial to inform prevention and harm reduction strategies," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
One in 10 Mental Health-Related ED Visits Among Youths Involve Boarding
WEDNESDAY, Aug. 20, 2025 -- Boarding is a considerable issue for Medicaid-enrolled youths seeking mental health care in emergency departments (EDs), according to a research letter...
College Students With Autism Report Higher Rates of Anxiety, Depression
TUESDAY, Aug. 19, 2025 -- College students with autism face higher rates of anxiety and depression than students without autism, according to a study recently published online in...
ADHD Drug Treatment Linked to Reduced Rate of Adverse Outcomes
THURSDAY, Aug. 14, 2025 -- Attention-deficit/hyperactivity disorder (ADHD) drug treatment is associated with reduced rates of adverse outcome events, including suicidality...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.